M32.0
Drug-induced systemic lupus erythematosus
HCC risk adjustment mapping
CMS-HCC ESRD V24
Rheumatoid Arthritis and Inflammatory Connective Tissue Disease
RxHCC V08
Systemic Lupus Erythematosus and Other Systemic Connective Tissue Disorders
Coding notes
Excludes 1 never coded together · Excludes 2 may co-exist
code for adverse effect, if applicable, to identify drug (T36-T50 with fifth or sixth character 5)
lupus erythematosus (discoid) (NOS) (L93.0)
autoimmune disease NOS collagen (vascular) disease NOS systemic autoimmune disease systemic collagen (vascular) disease
autoimmune disease, single organ or single cell-type -code to relevant condition category
arthropathic psoriasis (L40.5-) certain conditions originating in the perinatal period (P04-P96) certain infectious and parasitic diseases (A00-B99) compartment syndrome (traumatic) (T79.A-) complications of pregnancy, childbirth and the puerperium (O00-O9A) congenital malformations, deformations, and chromosomal abnormalities (Q00-Q99) endocrine, nutritional and metabolic diseases (E00-E88) injury, poisoning and certain other consequences of external causes (S00-T88) neoplasms (C00-D49) symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified (R00-R94)
Use an external cause code following the code for the musculoskeletal condition, if applicable, to identify the cause of the musculoskeletal condition (M00-M25) Arthropathies (M00-M25) Includes: Disorders affecting predominantly peripheral (limb) joints (M40-M54) Dorsopathies (M40-M54) (M60-M79) Soft tissue disorders (M60-M79) (M80-M94) Osteopathies and chondropathies (M80-M94)
Official Guidelines for M32.0
FY 2026 ›Find M32.0 in the alphabetic index
2 index paths lead to this code